Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02934659 · ClinicalTrials.gov registry record · NA
Atlas Knee System Clinical System Clinical Study (USA)
A NA study, sponsored by Moximed.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT02934659: Completed NA study, sponsored by Moximed.
NCT02934659 is a NA study that has completed, run by Moximed. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02934659, a NA study, has completed, sponsored by Moximed.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The primary objective of this pilot study is to collect data on the safety and effectiveness of the Atlas Knee System in subjects with medial knee osteoarthritis through 24 months postoperative follow-up.
Primary Outcome
1. WOMAC pain questions in the KOOS questionnaire (20% and 10 point improvement from baseline) 2. WOMAC function questions in the KOOS questionnaire (20% and 10 point improvement from baseline) 3. Maintenance of normal range of motion (ROM, knee flexion \>=90 degrees and knee extension within 10 degrees of neutral) 4. No subsequent surgical intervention of the medial knee; and no serious device-related adverse events 5. Maintenance of implant integrity as evaluated by radiographic assessment.
Interventions
- DEVICE Atlas(TM) Knee System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-11 |
| Est. Completion | 2023-05-02 |
| Phase | NA |
What the finished NCT02934659 record still lists
NCT02934659 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Atlas(TM) Knee System is the first listed.
NCT02934659 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02934659 about?
NCT02934659 is a clinical study titled "Atlas Knee System Clinical System Clinical Study (USA)". The primary objective of this pilot study is to collect data on the safety and effectiveness of the Atlas Knee System in subjects with medial knee osteoarthritis through 24 months postoperative follow-up.
What is the current status of trial NCT02934659?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2016-11. Estimated completion is 2023-05-02.
What interventions are being tested in trial NCT02934659?
The interventions under investigation include: Atlas(TM) Knee System (DEVICE).
Who is sponsoring clinical trial NCT02934659?
This trial is sponsored by Moximed, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02934659's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia